Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Community Health. 2015 Aug;40(4):633–641. doi: 10.1007/s10900-014-9978-8

Table 3.

MIRs for breast, cervical, colorectal, and prostate cancers, by HPSA designation

No HPSA
Partial HPSA
All HPSA
# of counties Mean ± SE p # of counties Mean ± SE p # of counties Mean ± SE p
Breast
No accessa 30 0.212 ± 0.009 0.278 11 0.238 ± 0.014 0.049 18 0.236 ± 0.015 0.099
Indirect accessb 251 0.199 ± 0.003 163 0.204 ± 0.004 150 0.216 ± 0.005
Direct accessc 155 0.205 ± 0.004 448 0.202 ± 0.002 386 0.208 ± 0.003
Cervix
No access 0 NA 0 NA 0 NA
Indirect access 9 0.342 ± 0.042 0.906 2 0.427 ± 0.072 0.148 2 0.601 ± 0.049 <0.001
Direct access 9 0.349 ± 0.031 115 0.321 ± 0.009 90 0.312 ± 0.007
Colorectal
No access 47 0.387 ± 0.011 0.959 27 0.376 ± 0.016 0.258 28 0.407 ± 0.016 0.376
Indirect access 304 0.383 ± 0.004 215 0.399 ± 0.006 225 0.404 ± 0.006
Direct access 172 0.384 ± 0.006 504 0.389 ± 0.004 477 0.395 ± 0.004
Prostate
No access 17 0.168 ± 0.014 0.558 8 0.201 ± 0.022 0.678 10 0.209 ± 0.021 0.007
Indirect access 210 0.184 ± 0.004 135 0.184 ± 0.005 113 0.209 ± 0.006
Direct access 130 0.182 ± 0.005 411 0.182 ± 0.003 349 0.186 ± 0.004

Bold values indicate statistical significant (p < 0.05)

MIR Mortality-to-Incidence Ratio, SE Standard Error, NA Data not available, HPSA Healthcare Professional Shortage Area

a

No FQHC delivery site both in the county and adjacent counties

b

No FQHC delivery site in the county, but any in adjacent counties

c

Any FQHC delivery sites in the county